le 24 mai, 2013
Désolé, la version française de cette page ne peut être offerte pour le moment.
Genetically Engineered Organisms: The Need to Consider Potential Economic Harm Prior to Commercial Release
CBAN was requested by the House of Commons Committee on Agriculture and Agri-Food to testify as part of their "biotechnology study": “...on the status of the Canadian biotechnology sector, in which it travels to the universities across Canada where this technology is primarily being undertaken, and that it recommend, where necessary, legislative, policy and regulatory changes in order to foster an innovative and fertile biotechnology industry in Canada.” CBAN Coordinator Lucy Sharratt testified on December 16, 2010 in a hearing with the President and Vice-President of industry lobby group CropLife. Click here to read the testimony. Below is the pdf Briefing submitted.